Deutsche Bank Ag\ Vericel Corp Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Vericel Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 40,109 shares of VCEL stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,109

Previous 32,238 24.42%

Holding current value

$2.3 Million

Previous $1.48 Million 14.54%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$42.25 - $53.56 $332,549 - $421,570	7,871 Added 24.42%	40,109 $1.69 Million
Q2 2024 Aug 14, 2024	SELL	$41.71 - $52.9 $124,128 - $157,430	-2,976 Reduced 8.45%	32,238 $1.48 Million
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $13,658 - $21,978	420 Added 1.21%	35,214 $1.83 Million
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $30,942 - $37,201	-1,003 Reduced 2.8%	34,794 $1.24 Million
Q3 2023 Nov 09, 2023	BUY	$31.69 - $39.25 $178,478 - $221,056	5,632 Added 18.67%	35,797 $1.2 Million
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $347,217 - $459,404	-11,973 Reduced 28.41%	30,165 $1.13 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $244,319 - $321,046	10,244 Added 32.12%	42,138 $1.24 Million
Q4 2022 Feb 13, 2023	BUY	$17.65 - $27.37 $161,056 - $249,751	9,125 Added 40.08%	31,894 $840,000
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $76,794 - $110,473	-3,395 Reduced 12.98%	22,769 $529,000
Q2 2022 Aug 11, 2022	SELL	$22.88 - $39.45 $76,579 - $132,039	-3,347 Reduced 11.34%	26,164 $659,000
Q1 2022 May 13, 2022	SELL	$31.69 - $43.29 $83,724 - $114,372	-2,642 Reduced 8.22%	29,511 $1.13 Million
Q4 2021 Feb 11, 2022	BUY	$35.2 - $52.6 $35,411 - $52,915	1,006 Added 3.23%	32,153 $1.26 Million
Q3 2021 Nov 04, 2021	SELL	$46.35 - $59.75 $1.04 Million - $1.34 Million	-22,467 Reduced 41.91%	31,147 $1.52 Million
Q2 2021 Aug 11, 2021	SELL	$47.2 - $67.81 $3.08 Million - $4.42 Million	-65,233 Reduced 54.89%	53,614 $2.82 Million
Q1 2021 May 13, 2021	BUY	$30.93 - $59.48 $2.57 Million - $4.94 Million	83,112 Added 232.58%	118,847 $6.6 Million
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $403,731 - $686,322	-21,788 Reduced 37.88%	35,735 $1.1 Million
Q3 2020 Nov 12, 2020	SELL	$14.68 - $19.12 $18,555 - $24,167	-1,264 Reduced 2.15%	57,523 $1.07 Million
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $347,165 - $646,136	40,843 Added 227.61%	58,787 $812,000
Q1 2020 May 14, 2020	SELL	$7.25 - $19.22 $417,810 - $1.11 Million	-57,629 Reduced 76.26%	17,944 $165,000
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $628,848 - $876,825	45,668 Added 152.71%	75,573 $1.31 Million
Q3 2019 Nov 14, 2019	BUY	$14.93 - $19.83 $149,688 - $198,815	10,026 Added 50.44%	29,905 $452,000
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $5.11 Million - $6.44 Million	-340,731 Reduced 94.49%	19,879 $373,000
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $1.99 Million - $2.49 Million	122,618 Added 51.52%	360,610 $6.31 Million
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $30,586 - $52,369	2,840 Added 1.21%	237,992 $4.14 Million
Q3 2018 Dec 21, 2021	BUY	$9.1 - $14.8 $1.28 Million - $2.08 Million	140,380 Added 148.12%	235,152 $3.33 Million
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $1.06 Million - $1.72 Million	-116,195 Reduced 55.08%	94,772 $1.34 Million
Q2 2018 Apr 21, 2020	BUY	$9.6 - $14.6 $113,011 - $171,871	11,772 Added 5.91%	210,967 $2.05 Million
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $683,404 - $1.04 Million	71,188 Added 55.61%	199,195 $1.93 Million
Q1 2018 Oct 18, 2019	SELL	$5.7 - $12.3 $228 - $492	-40 Reduced 0.03%	128,007 $1.27 Million
Q1 2018 May 15, 2018	BUY	$5.7 - $12.3 $722,799 - $1.56 Million	126,807 Added 10226.37%	128,047 $1.27 Million
Q4 2017 Feb 14, 2018	SELL	$3.65 - $5.98 $1.04 Million - $1.7 Million	-283,562 Reduced 99.56%	1,240 $6,000
Q3 2017 Nov 14, 2017	BUY	$3.0 - $6.0 $854,406 - $1.71 Million	284,802	284,802 $1.71 Million

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account